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Objective: To determine an ideal route and device in hysterectomy by comparing laparoendoscopic
single-site (LESS) hysterectomy with conventional laparoscopic-assisted vaginal hysterectomy (LAVH).
Methods: This is a computed clinical pathway based caseecontrol study performed in the Buddhist Tzu
Chi General Hospital, Hualien, Taiwan. Seventy-two patients (36 LESS hysterectomies and 36 LAVH) from
May 2011 to August 2013 were included. The choice of route of hysterectomy and Ligasure use during the
operation were made by the patient or by economic considerations. Perioperative outcomes, including
postoperative visual analog scale for pain and analgesic pain-relief score were compared.
Results: Surgical time and length of hospital stay were shorter in LESS hysterectomy than in LAVH
(126 ± 47.7 minutes vs. 158 ± 60.7 minutes and 4.7 ± 0.8 days vs. 5.4 ± 0.8 days, respectively). The visual
analog scale pain scores at 0e2 hours and 24 hours postoperation were signiﬁcantly lower in LESS
hysterectomy than in LAVH (5.68 ± 2.11 vs. 8.14 ± 1.46 and 3.75 ± 1.61 vs. 5.04 ± 1.28, respectively).
Overall, the pain score decreased by 30%, 26%, and 12% at 0e2 hours, 24 hours, and 48 hours, respectively,
after the operation. The total pain-relief score was 38.2% lower in LESS hysterectomy than in LAVH
(1.15 ± 0.44 vs. 1.86 ± 0.33; p < 0.001). There were comparable adverse events in both groups.
Conclusion: This study demonstrated that LESS hysterectomy with Ligasure is superior to conventional
LAVH.
Copyright © 2014, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Maturation in laparoscopic surgical techniques and improve-
ment in laparoendoscopic single-site surgery (LESS) tools in the
past decade have brought minimal invasive surgery towards a new
era. In the past 5 years, gynecological LESS has developed quickly
and continues to grow.1e4 Surgeons perform procedures similar to
those in traditional laparoscopic techniques, with the beneﬁt of a
single incision at the umbilicus, but, unlike a traditional multiport
laparoscopic approach, LESS leaves only a single small scar.2 This
provides signiﬁcant improvements in cosmetic value without any
apparent difference in efﬁcacy.5e7 The positive acceptance ofe no conﬂicts of interest.
nd Gynecology, Buddhist Tzu
3, Chung Yang Road, Hualien
g).
for Gynecologic Endoscopy and Minimminimal invasive surgery among patients in Taiwan is reﬂected by
the profound change in types of hysterectomy in the past 10 years,
with increasing laparoscopic-assisted vaginal hysterectomy (LAVH)
and decreasing total abdominal hysterectomy.8,9
Nonetheless, few articles discuss the optimal combination of
route and tool use in hysterectomy. No research has declared that
ﬂexible laparoscopic equipment is better than conventional
equipment in hysterectomy. Thus, the objective of this study is to
compare the perioperative outcomes of LESS hysterectomy, with or
without Ligasure, to LAVH and to determine the ideal combination
of route and device in hysterectomy.
Materials and methods
A caseecontrol study was conducted in the Buddhist Tzu Chi
General Hospital, Hualien, Taiwan between May 2011 and August
2013. Therewere 81 laparoscopic hysterectomies performed during
this period of study (Fig. 1). The exclusion criteria were: (1) age< 21ally Invasive Therapy. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Flow chart of study. LESS ¼ laparoendoscopic single-site surgery.
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previous history of radiation or pelvic inﬂammatory disease; (4)
gynecologic malignancy; and (5) allergy to nonsteroidal anti-
inﬂammatory drugs. The hospital's Research Ethics Committee
approved the study (IRB100-137).
In conventional LAVH, one 10 mm trocar was inserted supra- or
infraumbilicus, and two additional 5 mm ports were inserted
through the lower lateral abdominal wall. The LESS hysterectomies
were performed by a microsurgery team (D.C.D. and M.K.H.) in
procedures as previously described.2 Brieﬂy, a 2.0e2.5 cm vertical
incision wound through the umbilicus was made and a wound
retractor (Alexis; Applied Medical, Rancho Santa Margarita, CA,
USA) was inserted. A home-made adaptor composed of a surgical
glove and trocars was connected to the wound retractor. The
multiple ﬁngers of the glove functioned as multiports for the
laparoscopic instruments and camera. To optimize the range of
motion and operation ﬁeld, a rigid 5 mm laparoscope of 30 was
used.
Otherwise, all hysterectomies were performed with the con-
ventional laparoscopic straight tools or equipment, which included
the: (1) bipolar (Karl Storz, Tuttlingen, Germany) or Ligasure (Val-
leylab Inc., Boulder, CO, USA); (2) grasper (Mansﬁeld, MA, USA;
Autonomy, Cambridge Endoscopic Devices, Framingham, MA,
USA); and (3) scissors (Lagis, Taichung, Taiwan). Ligasure usage
required extra cost, it was decided based on the patient's economic
status or the patient's choice prior to the operation. After all of the
procedures were completed, Vicryl 3-0 was used for subcutaneous
closure of the skin wound in LAVH and coated Vicryl 0, 26 mm 5/8c
(Ethicon, Somerville, NJ, USA) was used for closure of the fascia and
subcutaneous skin in LESS hysterectomy.
Surgical time was deﬁned as the time from skin incision to
wound closure. Blood loss was calculated by subtracting the blood
volume in the suction bottle from the irrigation ﬂuid. The visualanalog scale (VAS) for pain was used to rate the postoperative pain
intensity at three different time points: 0e2 hours, 24 hours, and 48
hours postoperatively. To optimize the accuracy of pain estimation
and minimize the mask effect of pain of analgesics used intra-
operatively or painkillers used postsurgery, some adjustments
were made in measuring the VAS pain score. Instead of evaluating
the pain score right after the operation, when the patient was still
relatively unclear, the ﬁrst postoperative VAS pain score was
deﬁned as the highest score within 2 hours postoperatively, when
operative analgesics were about to be eliminated. Second, if the
patient used analgesics when the 24- and 48-hour pain scores were
to be evaluated, then the VAS score at least 2 hours apart was
recorded.
In the study hospital, the computed LAVH clinical pathway had
been used for several years. In the clinical pathway, two kinds of
intravenous analgesic were available: ketorolac 30 mg (Yung Shin
Pharm. Ind. Co., Ltd, Taichung, Taiwan) and morphine 10 mg
(Restricted Drug Factory of Food and Drug Administration, Ministry
of Health and Welfare, Taipei, Taiwan). Two kinds of oral analgesic
were also available: acetaminophen 500 mg (YungShin Pharm. Ind.
Co., Ltd, Taichung, Taiwan) and naproxen 250 mg (China Chemical
& Pharmaceutical Co., Ltd, Hsinchu, Taiwan). These were given
based on the patient's need, although acetaminophen was usually
given to a patient initially and then changed to naproxen if needed.
To compare postoperative pain objectively, the type and accu-
mulated dose of analgesics used by each patient was calculated and
converted to a pain-relief score according to number needed to
treat (NNT) of the Oxford League Table of Analgesic Efﬁcacy. The
NNT is a system developed to compare the effectiveness of different
analgesic drugs by providing an indication of how many analgesic
had to be given to before one patients perceives 50% pain relief
lasting for 4 hours. For the clinical sense and easier understanding
by the general reader, the NNT of an analgesic was converted to the
term “pain-relief score” and deﬁned as [1/NNT]. Therefore, the
pain-relief score of each ketorolac 30 mg/amp, morphine 10 mg/
amp, acetaminophen 500 mg/tablet, and naproxen 10 mg/tablet
were 0.294, 0.345, 0.286, and 0.323 respectively. As such, the total
pain-relief score of a patient had during the 48 hours postoperation
was equal to the sum of [number of NNT]  [1/NNT] of every single
painkiller used. For example, during the period of 48 hours post-
operation, Patient A used acetaminophen 2000 mg and 20 mg
morphine but Patient B used acetaminophen 2000 mg and
morphine 10 mg, so the pain-relief score of A ¼ (2000/
500)  0.286 þ (20/10)  0.344 ¼ 1.832; and B ¼ (2000/
500)  0.286 þ (10/10)  0.344 ¼ 1.488.
The Sample Size Calculator (G Power 3.1) was used to determine
the appropriate sample size. Setting power to 0.8, type I error (a) to
0.05, and allocation ratio of each group to 1:1, a total of 72 cases
were needed. Data are expressed as frequencies, proportions, or
means ± standard deviations, depending on the characteristics of
each item. Student t test was used to compare the means of
continuous variables between different groups. Statistical signiﬁ-
cance was set at p < 0.05. All of the statistical analyses were per-
formed using the SPSS software (version 17.0; SPSS Inc., Chicago, IL,
USA).
Results
Of the 81 cases initially included, 9 were excluded due to
moderate-to-severe pelvic adhesions or nonsteroidal anti-
inﬂammatory drugs allergy (Fig. 1). Seventy-two patients were
ﬁnally included (36 LAVH and 36 LESS hysterectomy), of whom 44%
(33/75) were postmenopausal (Table 1). Themean bodymass index
was 26.6 ± 5.1 kg/m2 (range, 20.5e38.8 kg/m2). There was no sig-
niﬁcant difference in the patients' characteristics or additional
Table 1
Characteristics and perioperative outcomes of the study patients (n ¼ 72).
Parameters LESS hysterectomy
(n ¼ 36)
LAVH
(n ¼ 36)
p Mean ± SD
Patient characteristics
Age (y) 45.0 ± 4.47 45.0 ± 11.0 0.256 45.0 ± 8.0
BMI (kg/m2) 25.4 ± 5.0 26.9 ± 8.0 0.421 26.6 ± 5.1
Mild pelvic adhesion 10 (27.7) 8 (20.5) 0.586 18 (25)
Operations
Total hysterectomy
alone
13 (36.1) 19 (48.7) 32 (42.7)
Total hysterectomy
þ BS
13 (36.1) 12 (30.7) 25 (33.3)
Total hysterectomy
þ BS þ AD
10 (27.7) 8 (20.5) 18 (24)
Perioperative outcome
Uterine length (cm) 10.2 ± 2.6 8.9 ± 4.7 0.259 10.6 ± 2.2
Uterine width (cm) 7.6 ± 2.2 6.5 ± 3.5 0.184 7.8 ± 1.8
Surgical time (min) 126 ± 47.7 158 ± 60.7 0.046* 139 ± 54
Blood loss (mL) 392 ± 355 316 ± 174 0.368 359 ± 288
Hospitalization (d) 4.7 ± 0.8 5.4 ± 0.8 0.004* 5.0 ± 0.8
Data are presented as mean ± standard deviation or n (%).
*p < 0.05 was considered statistically signiﬁcant after the test.
AD ¼ adhesiolysis; BMI ¼ body mass index; BS ¼ bilateral salpingectomy;
LAVH ¼ laparoscopic-assisted vaginal hysterectomy; LESS ¼ laparoendoscopic
single-site; SD ¼ standard deviation.
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dex, uterine size, bilateral salpingectomy, and the number of mild
pelvic adhesion. Ten patients (27.7%) in the LESS hysterectomy
group and eight (20.5%) patients in the LAVH group had mild pelvic
adhesion and received adhesiolysis during surgery.
The surgical time and length of hospitalization in the LESS
hysterectomy group were signiﬁcantly shorter compared to the
LAVH group (126 ± 47.7 vs. 158 ± 60.7min and 4.7 ± 0.8 vs. 5.4 ± 0.8
days, respectively). A total of 86.1% (31/36) patients in the LESS
hysterectomy group and 48.7% (19/39) in the LAVH group used
Ligasure. The estimated blood loss and uterine size were compa-
rable in the two groups.
The VAS pain score was signiﬁcantly lower in the LESS hyster-
ectomy group than in the LAVH group at 0e2 hours and 24 hours
postoperatively (5.68 ± 2.11 vs. 8.14 ± 1.46 and 3.75 ± 1.61 vs.
5.04 ± 1.28, respectively; Table 2; Fig. 2A). The difference in VAS
pain score between the two groups was greatest at 0~2 hours
postoperatively and gradually decreased at 24 hours and 48 hours
(Table 2, Fig. 2B). Overall, the VAS pain score of the LESS hyster-
ectomy group at 0e2 hours, 24 hours, and 48 hours after surgery
decreased by 30%, 26%, and 11.9%, respectively, compared to the
LAVH group. The total pain-relief score was 38.2% less in the LESS
hysterectomy group (1.15 ± 0.44) than in the LAVH group
(1.86 ± 0.33; p < 0.001).Adverse events
The adverse events in the two groups were comparable. There
was a total of 13 intra- or postoperative adverse events (Table 3),Table 2
Comparison of postoperative pain.
Time LESS hysterectomy LAVH p
VAS pain score 0e2 h 5.68 ± 2.11 8.14 ± 1.46 <0.001*
24 h 3.75 ± 1.61 5.04 ± 1.28 <0.001*
48 h 2.25 ± 1.59 2.51 ± 1.37 0.452
Pain-relief score 1.15 ± 0.44 1.86 ± 0.33 <0.001*
* Pain score and pain-relief score difference between groups is signiﬁcant (p ¼ 0.01)
with t test.
LAVH ¼ laparoscopic-assisted vaginal hysterectomy; LESS ¼ laparoendoscopic sin-
gle-site.including two bladder injuries, three blood loss >1000 mL, two
poor wound healing, and six postoperative shoulder pain. In gen-
eral, there was no signiﬁcant difference in complication rate be-
tween the two groups (6 of 36, 1.66% vs. 7 of 36, 1.94%). Three cases
of massive blood loss were noted in this study (2 in the LESS hys-
terectomy group and 1 in the LAVH group). One was a case of
enlarged uterus (about 18 cm  14 cm) with a large leiomyoma
(about 10 cm in diameter, weight 750 g) over the posterior uterine
wall. The other two were also cases of enlarged uterus with ade-
nomyosis and severe chronic anemiadone had intestinal adhesion
and the other had a history ofmultiple previous cesarean deliveries.
The LAVH group had more cases of postoperative shoulder pain
compared to LESS hysterectomy group (4 cases vs. 2 cases,
respectively), whichmight be due to the longer surgical time. There
was one case of bladder injury and one case of poor healing trocar
wound with some aseptic discharges in both groups. The bladder
injury was sutured with chromic 0 and maintained normal bladder
function on follow-up, whereas the trocar wounds were managed
by wet dressing. These wounds healed about 10 days after surgery.
Discussion
This study demonstrates that LESS hysterectomy with Ligasure
is superior to LAVH in terms of shorter surgical time and hospi-
talization, less postoperative pain, and less use of analgesics. Unlike
a traditional multiport laparoscopic approach, LESS leaves only a
single small scar that becomes “scarless” when healed, which is
also cosmetically more appealing. Based on these advantages, LESS
hysterectomy with Ligasure is one of the ideal combinations of
route and device in hysterectomy and it may become the most
popular route and tool in hysterectomy in the near future.10
There is anatomic and histologic fundamental evidence sup-
porting the ﬁndings of less postoperative pain and faster recovery
in LESS.11e13 The umbilicus is avascular and is also the thinnest area
of the abdominal wall. Thus, it is the best place to introduce the
trocar of laparoscopy. Moreover, the nerve innervation at the
abdomenwall and umbilicus originate from the lumbar spinal cord
and extend via the abdominal wall bilaterally to the abdominal
midline. As such, the midline of the abdomen or umbilicus is the
area where it is most insensitive to pain. Nonetheless, a vertical
umbilical incision is recommended rather than a transverse one in
order to achieve the goals of minimal invasiveness and less post-
surgical pain. In LAVH, twomore trocars have to be introduced over
the bilateral site of the lower abdomen where injury to the muscle
and fascia is inevitable. All of this can explain why LESS hysterec-
tomy gives signiﬁcantly less pain than LAVH at different time points
postoperatively.1,14
In this study, the difference in postoperative pain is the greatest
within 2 hours after the operation, and then decreases gradually
thereafter. This ﬁnding is totally different from a previous study in
which the difference in pain is smallest 12 hours postoperatively
and then gradually increases at 24 hours and 48 hours post-
operatively.1,14 This unexpected ﬁndingmay due to the difference in
study design. In this study, the masking effect of operative anal-
gesics on VAS pain score has been considered. The ﬁrst post-
operative VAS pain was evaluated by asking about the maximum
pain within 2 hours postoperatively, when operative analgesics
were about to be totally eliminated and the consciousness of pa-
tient was relatively clearer.
The female uterus is at the midline of the pelvis and the pro-
cedures involved in laparoscopic hysterectomy do not need wide
angulations. As such, the approach via LESS is easier. The use of
Ligasure further fastens the laparoscopic part in hysterectomy
either via LESS or conventional LAVH.15 The surprising advantage of
shorter surgical time in LESS hysterectomy is actually due to the use
Fig. 2. Postoperative pain score. (A) Visual analog scale (VAS); (B) Pain-relief score. LESS ¼ laparoendoscopic single-site surgery. ***p < 0.001.
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in LAVH). However, this advantage disappears in LESS adnexal
surgeries, including salpingo-oophorectomy and cystectomy,
compared to laparoscopic adnexal surgeries (data not shown).
There was no difference between groups in terms of pain relief
score and postoperative VAS pain score.
This study had some strengths. First, the computed clinical
pathway provides a fair fundamental condition for the comparison
of analgesic use after surgery. All patients have been given anal-
gesics as needed. Second, postoperative pain is evaluated in a
subjective and objective manner. Considering the pain-masking
effect and altered cognitive function by analgesic use during sur-
gery, the VAS pain score was evaluated within 2 hours post-
operatively by asking the patient with a maximum pain score
within these 2 hours. The type and accumulated dose of analgesics
use in every patient were recorded and converted to the pain-relief
score. Moreover, the data on the pain-relief score were highly
conﬁdential and could objectively reﬂect the pain condition of
patients after operation.
Nonetheless, this study also has some limitations. For one, it is
not a randomized trial. The surgeries were not conducted by the
same surgeon and concomitant surgery might have an effect on the
evaluation of pain. Concomitant surgeries may increase the post-
operative pain, but this bias is considered minimal because the
distributions of concomitant surgeries are balanced in the two
groups.
This study demonstrates that LESS hysterectomy with Ligasure
provides advantages for patients who are indicated for hysterec-
tomy.16 When patients can return to work a shorter time after
operation, this can improve productivity and help in social eco-
nomics. This is especially valuable in many countries that lack
health personnel. The lower analgesic use and shorter hospitali-
zation will also save medical resources. In addition, under the
diagnosis-related global budget medical payment system in
Taiwan, less hospitalization will result in more proﬁt for the hos-
pital. From the patient's viewpoint, reduced pain and faster re-
covery from surgery will deﬁnitely improve their satisfaction.Table 3
Perioperative adverse events.
Adverse event LESS hysterectomy LAVH
Bladder injury 1 1
Blood loss >1000 mL 2 1
Wound poor healing 1 1
Postoperative shoulder pain 2 4
Total 6 7
LAVH ¼ laparoscopic-assisted vaginal hysterectomy; LESS ¼ laparoendoscopic sin-
gle-site.Based on these analyses, it is reasonable to predict that another
trend of hysterectomy is starting and that LESS hysterectomy with
or without Ligasure will most probably become a popular surgery
in the next 10 years, especially in Taiwan.
Conclusion
In conclusion, LESS hysterectomy with Ligasure is superior to
conventional LAVH in terms of shorter surgical time and hospital-
ization, less postoperative pain, less analgesic use, and a “scarless”
wound. It is an ideal combination of route and device in
hysterectomy.
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